Fundraising Fox
/Companies
Sign in

Adagio Medical Holdings

NASDAQ: ADGM

Laguna Hills, US · Delaware corporation · 1 known investors

Find your way into Adagio Medical Holdings

Sign up to see every warm intro you have to Adagio Medical Holdings

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adagio Medical Holdings team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Adagio Medical Holdings develops and commercializes catheter-based ablation devices using proprietary Ultra-Low Temperature Ablation technology to treat ventricular tachycardia, a life-threatening abnormal heart rhythm, primarily in patients with structural heart disease. The company's vCLAS Cryoablation System creates deep lesions in heart muscle tissue to eliminate abnormal electrical pathways and has received European regulatory approval and FDA Breakthrough Device designation.

Healthtech

Founders & leadership

TUTodd Usen
Todd UsenExecutiveTodd Usen is an executive with experience in medical device companies including roles leading organizational restructuring and product development at Minerva Surgical, serving as founding CEO of Activ Surgical (which raised $92 million and obtained FDA and CE mark clearances), and leading the medical business expansion at Olympus as President of Medical.
DK
Deborah KasterExecutiveDeborah Kaster is Chief Financial Officer of Adagio Medical Holdings and leads strategy, business development, and investor relations for the electrophysiology device company. She previously spent five years as a medical device investment banker and served in business development at a public company that was acquired for approximately $4 billion, and has worked as an independent consultant on M&A and due diligence for healthcare companies and private equity firms.

Board

KM
Keyvan Mirsaeedi-FarahaniBoard director
OM
Orly MishanBoard director
JL
James L. CoxBoard director
TP
Timothy P. MoranBoard director
SG
Sandra GardinerBoard director

Investors · 1

RA CapitalreportedBoston

How we know: the S-1 prospectus · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$19M disclosed across 1 round · 2025

▶$19MraisedOct 2025 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Keyvan Mirsaeedi-FarahaniDirector
  • Todd UsenExecutive Officer, Director
  • Deborah KasterExecutive Officer
  • James L. CoxDirector
  • Orly MishanDirector
  • Timothy P. MoranDirector
  • Sandra GardinerDirector
Offering amount
$49.8M
Amount sold
$19M
Finders' fees
$1.2M
Placement agents
Piper Sandler & Co.
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Adagio Medical Holdings do?
Adagio Medical Holdings develops and commercializes catheter-based ablation devices using proprietary Ultra-Low Temperature Ablation technology to treat ventricular tachycardia, a life-threatening abnormal heart rhythm, primarily in patients with structural heart disease. The company's vCLAS Cryoablation System creates deep lesions in heart muscle tissue to eliminate abnormal electrical pathways and has received European regulatory approval and FDA Breakthrough Device designation.
Who are Adagio Medical Holdings's investors?
Adagio Medical Holdings's investors include RA Capital.
How much funding has Adagio Medical Holdings raised?
Adagio Medical Holdings has disclosed $19M raised across 1 round.
Where is Adagio Medical Holdings headquartered?
Adagio Medical Holdings is headquartered in Laguna Hills, US.